Healthcare Industry News: Magnetic Resonance Imaging
News Release - November 27, 2018
SyMRI Software and Philips Ingenia Elition 3.0T MR are now Jointly Marketed in the USASTOCKHOLM, Nov. 27, 2018 -- (Healthcare Sales & Marketing Network) -- The SyMRI NEURO software from SyntheticMR AB and the Philips Ingenia Elition 3.0T MR scanner with the synthetic SyntAc sequence are now jointly marketed in the United States.
The data generated from a single SyntAc scan on the Philips MRI and SyMRI software can generate multiple contrast-weighted images and volumetric information, to support a fast examination and provide more information to the clinician. The product includes the industry's first measurements of myelin correlated volumes.
"Philips and SyntheticMR have with this step made concrete the journey to make quantitative MRI of the brain through SyMRI a part of the clinical workflow," says Jonas Hurtig, Head of Marketing and Commercial Affairs at SyntheticMR AB.
"This is a positive step in the collaboration between Philips and SyntheticMR in general and for the US market in particular," says Paul Folkers, Head of Clinical Science for MRI at Philips. "We are now looking forward to make this technology part of the clinical routine together."
SyMRI software and the SyntAc sequence can now be sold on Philips Ingenia Elition 3.0T MR systems in the US.
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI® delivering multiple, adjustable contrast images and quantitative data from a single 5-6-minute scan – generating increased patient throughput and objective decision support for clinicians. SyMRI is CE-marked and FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the Spotlight Stock Market in Stockholm, Sweden. For additional information, please visit www.syntheticmr.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.